Skip to main content
. 2020 Sep 18;10:519388. doi: 10.3389/fonc.2020.519388

Figure 4.

Figure 4

Forest plots of network comparisons of effect of combination therapies compared to ADT alone on overall survival (A) and failure-free survival (B). Rankings are presented as probabilities of ranking first and SUCRA. Doc, docetaxel; Abi, abiraterone; Enza, enzalutamide; Apa, apalutamide; ADT, androgen-deprivation therapy.